Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Operating activities
Net earnings	$ 21,690	$ 27,712
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	11,559	11,519
Gain on sale of property and equipment	38	(182)
Reclassification of foreign currency translation adjustment related to disposal of subsidiary	0	191
Share-based compensation expense	1,885	1,583
Inventory write-offs for obsolescence	1,567	1,451
Deferred income taxes	691	(72)
Foreign currency impacts and other items	(2,755)	(3,550)
Net changes in operating assets and liabilities:
Accounts receivable	1,604	(2,077)
Inventories	(7,811)	(14,151)
Prepaid expenses and other current assets	1,990	(984)
Trade accounts payable	(1,151)	(1,459)
Other current liabilities	(1,082)	1,303
Other non current assets and liabilities, net	(170)	(326)
Accrued pension and other postretirement costs, net	(945)	(443)
Net cash provided by operating activities	27,110	20,515
Investing activities
Capital expenditures	(9,848)	(15,545)
Proceeds from sale of property and equipment	50	397
Purchase of short term investment	(1,000)	0
Net cash used in investing activities	(10,798)	(15,148)
Financing activities
Payments on revolving facility	(7,000)
Purchase of treasury stock	(1,196)	(1,061)
Distributions to noncontrolling interests	(138)	(366)
Payments of employee taxes on certain share-based arrangements	(825)	(435)
Net cash used in financing activities	(9,159)	(1,862)
Effect of exchange rate changes on cash and cash equivalents	(1,083)	(7,930)
Increase (decrease) in cash and cash equivalents	6,070	(4,425)
Cash and cash equivalents at beginning of period	88,562	84,335
Cash and cash equivalents at end of period	94,632	79,910
Supplemental disclosure of investing transactions:
Capital expenditures accrued but not yet paid	$ 1,204	$ 720